News
- Author:
- Miriam E. Tucker
Publish date: July 30, 2021
Almost two-thirds of study participants had at least one diabetes complication in young adulthood, around 15 years after diagnosis. A handful died,...
News
- Author:
- Miriam E. Tucker
Publish date: July 29, 2021
The approval will allow Semglee to function like a generic drug in the market and may reduce insulin costs.
News
- Author:
- Miriam E. Tucker
Publish date: July 23, 2021
It’s the second GLP-1 receptor agonist approved for youth with type 2 diabetes, and the first once-weekly.
News
- Author:
- Miriam E. Tucker
Publish date: July 21, 2021
The HFX implanted device provides significant pain relief beyond conventional treatment in patients with refracto...
News
- Author:
- Miriam E. Tucker
Publish date: July 20, 2021
Large European study finds lower all-cause and cardiovascular death over 5 years among regular bike riders, even ...
News
- Author:
- Miriam E. Tucker
Publish date: July 14, 2021
The new draft ADA/EASD consensus report offers an algorithm for diagnosing type 1 diabetes, a clear call for state-of-the-art technology, and an em...
News
- Author:
- Miriam E. Tucker
Publish date: July 12, 2021
Simultaneous pancreas-kidney transplants are increasingly performed in patients with type 2 diabetes and chronic kidney disease.
News
- Author:
- Miriam E. Tucker
Publish date: July 7, 2021
The decision follows narrow endorsement by an advisory panel.
News
- Author:
- Miriam E. Tucker
Publish date: June 27, 2021
If approved by the FDA, it would be the third commercially available semiautomated insulin delivery system in the United States and the first witho...
News
- Author:
- Miriam E. Tucker
Publish date: June 26, 2021
Two new studies show a shocking increase in type 2 diabetes among U.S. children during the pandemic, with increased severity at presentation. Black...
News
- Author:
- Miriam E. Tucker
Publish date: June 23, 2021
A new drug class and a rare comparative effectiveness study for type 2 diabetes, management of type 1 diabetes in adults, COVID-19 and diabetes, an...
News
- Author:
- Miriam E. Tucker
Publish date: June 18, 2021
A large survey is believed to be the first to explore the common phenomenon and identify potential avenues of treatment.
News
- Author:
- Miriam E. Tucker
Publish date: June 17, 2021
The Centers for Medicare & Medicaid Services has removed requirements for thrice-daily blood glucose measurement and allowed CGM coverage for t...
News
- Author:
- Miriam E. Tucker
Publish date: June 16, 2021
Analysis from the U.K. Biobank finds that persons with “metabolically healthy obesity” still have increased risks for several adverse outcomes, com...
News
- Author:
- Miriam E. Tucker
Publish date: June 1, 2021
Current knowledge on insulin pumps, continuous glucose monitors, automated insulin delivery systems, ‘smart’ pens, telemedicine, apps, and implemen...
